As highlighted, S100A8/A9 and resistin enhances the ability to distinguish sepsis patients from healthy individuals, assess the severity of sepsis, identify the infecting bacterial type, perform immunotyping of sepsis patients, and predict patient survival outcomes. The gene discussed is RETN; the disease is Sepsis.